Publication | Closed Access
Sulforaphane attenuation of experimental diabetic nephropathy involves GSK-3 beta/Fyn/Nrf2 signaling pathway
100
Citations
33
References
2015
Year
Metabolic SyndromeRenal FunctionBiochemistryMedicineDiabetesPharmacologySulforaphane AttenuationDiabetic Kidney DiseaseGsk-3 Beta/fyn/nrf2MetabolismChronic Kidney DiseaseCell SignalingNephrologyKidney ResearchOxidative Stress
| Year | Citations | |
|---|---|---|
Page 1
Page 1